Mark this Date on Your Calendar: “Trump’s AI Day”

Join Louis Navellier on Wednesday, July 9, 8 pm ET

Wed, July 9 at 8:00PM ET
 
 
 
 
Register Here

Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Why Short-Term Investors Should Avoid Shopify Stock

By Thomas Niel, InvestorPlace Contributor
Short term, SHOP stock is a sell. A massive pullback could signal a buying opportunity to place a bet on Shopify's future prospects. But until then, investors should be cautious before chasing this growth story.

It’s Time to Wait for Lower Prices on Tesla Stock

By David Moadel, InvestorPlace Contributor
You don't have to be a hater, but it will pay to be cautious on TSLA stock now. Here's what you need to know about Tesla today.

Possible Margin Compression Turns Wells Fargo Stock Watchers Bearish

By Faisal Humayun, InvestorPlace Contributor
Wells Fargo stock watchers are showing concern that the impact of potential consumer deleveraging can take WFC stock lower.

Cronos Needs to Show the Market Something to Pull Stock Out of Funk

By James Brumley, InvestorPlace Feature Writer
CRON stock is putting pressure on the 200-day moving average line, as a floor, and Cronos Group can to little to relieve it.

4 Healthcare Stocks That Are Feeling Sick  

By William Roth, InvestorPlace Market Strategist
These healthcare stocks are breaking down on the charts. Investors should be careful before stepping into these four.

Should the Owners of GE Stock Take Their Profits?

By Will Ashworth, InvestorPlace Contributor
Don’t look now but General Electric stock is up 37% in 2019 including dividends through July 10. Will GE stock continue to rise?

AT&T Is Not Worth Buying Just for Its 6% Yield

By Will Ashworth, InvestorPlace Contributor
A lot of investors love the 6% dividend yield AT&T offers. Here’s why you should never buy T stock just for its yield.   

Investors Should Not Expect Nio Stock to Keep Cruising Higher

By Will Healy, InvestorPlace Contributor
The recent rally in Nio stock has many wondering if NIO will turnaround, but the company remains financially troubled despite higher sales.

The Tech Behind PLUG Stock Still Needs to Catch Up to the Promises

By Josh Enomoto, InvestorPlace Contributor
Enthusiasm over Plug Power's alternative-energy technologies currently drives PLUG stock, but practically speaking, the tech is still too expensive.

Aurora Cannabis: Here’s Why ACB Stock Continues to Sink

By Ian Bezek, InvestorPlace Contributor
Tempted to buy the dip in ACB stock? Here's why things are likely to get worse before things turn around for Aurora.

After Three-Fold Rally, Roku Stock Is Overvalued

By Thomas Niel, InvestorPlace Contributor
ROKU stock is up three-fold year-to-date. But despite strong growth and takeover rumors, Roku has entered overvalued territory.

Despite Its Recent Strength, Snap Stock Is Played out for This Year

By Luke Lango, InvestorPlace Senior Investment Analyst
Although the fundamentals are improving, further upside in SNAP stock seems unlikely given the stock's already stretched valuation.

Investors Eyeing GM Stock Should Remain on Sidelines Until Headwinds Ebb

By Faisal Humayun, InvestorPlace Contributor
GM stock has remained sideways. Economic concerns overshadow General Motors new launches and growth in crossover segment.

Stock Showdown: AT&T Stock and Verizon Are Both Risky Plays

By Aaron Levitt, InvestorPlace Contributor
Both AT&T and Verizon are dividend staples. But recent moves have made both T stock and VZ stock pretty risky.

Tesla Stock Deliveries Rally Fizzles, Now What?

By Wayne Duggan, InvestorPlace Contributor
Tesla beat expectations with its second-quarter deliveries number. However, investors soon realized it didn't change TSLA stock's outlook.

4 Drug Stocks Getting Smashed

By William Roth, InvestorPlace Market Strategist
Drug stocks are falling on fears of President Trump's next move on drug prices. Here's a look at the charts.

Nvidia Stock May Be Bottoming, But Don’t Expect a Recovery in 2019

By Ian Bezek, InvestorPlace Contributor
NVDA's business continues to struggle. With the trade war causing more damage, there's no reason to get excited about Nvidia stock yet.

Too Many Technical and Fundamental Questions Plague Aurora Stock

By Mark Putrino, CMT
I would not buy Aurora stock at current levels. Simply put, the stock has underperformed and I don't think this will change anytime soon.

Can Larry Culp Really Save General Electric Stock?

By Ian Bezek, InvestorPlace Contributor
Is GE stock set to turn things around, or will its slump get even worse? Here's all the information that you need to know about General Electric for the rest of 2019.
Load More Articles